SCOPUS 정보 검색 플랫폼

OncoImmunology

Volumn 4, Issue 10, 2015, Pages

Innate vs. Adaptive: PD-L1-mediated immune resistance by melanoma

(2) Berry, Sneha a Taube, Janis M a

a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE (United States)

Author keywords

adaptive immune resistance; BRAF; melanoma; PD L1; TIL

Indexed keywords

B RAF KINASE; DABRAFENIB; GAMMA INTERFERON; INTERLEUKIN 10; PROGRAMMED DEATH 1 LIGAND 1; TUMOR ANTIGEN; VEMURAFENIB;

ADAPTIVE IMMUNITY; ARTICLE; CLINICAL TRIAL (TOPIC); HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC INFILTRATION; MELANOMA; MONOTHERAPY; MUTATIONAL ANALYSIS; PROTEIN EXPRESSION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT; UPREGULATION;

EID: 84940706565 PISSN: 21624011 EISSN: 2162402X Source Type: Journal
DOI: 10.1080/2162402X.2015.1029704 Document Type: Article

Times cited : (28)

References (10)

1
- 33846118474
- Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma
- 17159987
- A.T.Parsa, J.S.Waldron, A.Panner, C.A.Crane, I.F.Parney, J.J.Barry, K.E.Cachola, J.C.Murray, T.Tihan, M.C.Jensen, et al. Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma. Nat Med 2007; 13(1):84-8; PMID:17159987; http://dx.doi.org/10.1038/nm1517
- (2007) Nat Med , vol.13 , Issue.1 , pp. 84-88
- Parsa, A.T.¹ Waldron, J.S.² Panner, A.³ Crane, C.A.⁴ Parney, I.F.⁵ Barry, J.J.⁶ Cachola, K.E.⁷ Murray, J.C.⁸ Tihan, T.⁹ Jensen, M.C.¹⁰

2
- 78049370405
- Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma
- 20628145
- M.R.Green, S.Monti, S.J.Rodig, P.Juszczynski, T.Currie, E.O'Donnell, B.Chapuy, K.Takeyama, D.Neuberg, T.R.Golub, et al. Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma. Blood 2010; 116(17):3268-77; PMID:20628145; http://dx.doi.org/10.1182/blood-2010-05-282780
- (2010) Blood , vol.116 , Issue.17 , pp. 3268-3277
- Green, M.R.¹ Monti, S.² Rodig, S.J.³ Juszczynski, P.⁴ Currie, T.⁵ O'Donnell, E.⁶ Chapuy, B.⁷ Takeyama, K.⁸ Neuberg, D.⁹ Golub, T.R.¹⁰

3
- 84903831602
- Effects of MAPK and PI3K pathways on P-L1 expression in melanoma
- M.Atefi, E.Avramis, A.Lassen, D.J.Wong, L.Robert, D.Foulad, M.Cerniglia, B.Titz, T.Chodon, T.G.Graeber, et al. Effects of MAPK and PI3K pathways on P-L1 expression in melanoma. Clin Can Res 2014; 20(13):3446-57; http://dx.doi.org/10.1158/1078-0432.CCR-13-2797
- (2014) Clin Can Res , vol.20 , Issue.13 , pp. 3446-3457
- Atefi, M.¹ Avramis, E.² Lassen, A.³ Wong, D.J.⁴ Robert, L.⁵ Foulad, D.⁶ Cerniglia, M.⁷ Titz, B.⁸ Chodon, T.⁹ Graeber, T.G.¹⁰

4
- 84859128199
- Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape
- 22461641
- J.M.Taube, R.A.Anders, G.D.Young, H.Xu, R.Sharma, T.L.McMiller, S.Chen, A.P.Klein, D.M.Pardoll, S.L.Topalian, et al. Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape. Sci Transl Med 2012; 4(127):127ra37; PMID:22461641; http://dx.doi.org/10.1126/scitranslmed.3003689
- (2012) Sci Transl Med , vol.4 , Issue.127 , pp. 127ra37
- Taube, J.M.¹ Anders, R.A.² Young, G.D.³ Xu, H.⁴ Sharma, R.⁵ McMiller, T.L.⁶ Chen, S.⁷ Klein, A.P.⁸ Pardoll, D.M.⁹ Topalian, S.L.¹⁰

5
- 84891528539
- PD-L1 expression in the Merkel cell carcinoma microenvironment: association with inflammation, Merkel cell polyomavirus and overall survival
- 24416729
- E.J.Lipson, J.G.Vincent, M.Loyo, L.T.Kagohara, B.S.Luber, H.Wang, H.Xu, S.K.Nayar, T.S.Wang, D.Sidransky, et al. PD-L1 expression in the Merkel cell carcinoma microenvironment: association with inflammation, Merkel cell polyomavirus and overall survival. Cancer Immunol Res 2013; 1(1):54-63; PMID:24416729; http://dx.doi.org/10.1158/2326-6066.CIR-13-0034
- (2013) Cancer Immunol Res , vol.1 , Issue.1 , pp. 54-63
- Lipson, E.J.¹ Vincent, J.G.² Loyo, M.³ Kagohara, L.T.⁴ Luber, B.S.⁵ Wang, H.⁶ Xu, H.⁷ Nayar, S.K.⁸ Wang, T.S.⁹ Sidransky, D.¹⁰

6
- 84940645373
- Differential expression of immuno-regulatory genes associated with PD-L1 display: implications for clinical blockade of the PD-1/PD-L1 pathway in melanoma
- G.D.Young, T.L.McMiller, H.Xu, S.Chen, A.E.Berger, J.Fan, R.A.Anders, C.Cheadle, D.M.Pradoll, S.L.Topalian,, et al. Differential expression of immuno-regulatory genes associated with PD-L1 display: implications for clinical blockade of the PD-1/PD-L1 pathway in melanoma. Cancer Res 2013; 73:6-10; http://dx.doi.org/10.1158/1538-7445.AM2013-6
- (2013) Cancer Res , vol.73 , pp. 6-10
- Young, G.D.¹ McMiller, T.L.² Xu, H.³ Chen, S.⁴ Berger, A.E.⁵ Fan, J.⁶ Anders, R.A.⁷ Cheadle, C.⁸ Pradoll, D.M.⁹ Topalian, S.L.¹⁰

7
- 84962232340
- PD-L1 expression in melanocytic lesions does not correlate with the BRAF V600E mutation
- 25370533
- N.Rodic, R.A.Anders, J.R.Eshleman, M.Lin, H.Xu, J.H.Kim, K.Beierl, S.Chen, B.S.Luber, H.Wang, et al. PD-L1 expression in melanocytic lesions does not correlate with the BRAF V600E mutation. Cancer Immunol Res. 2015; 3(2):110-5; PMID:25370533; http://dx.doi.org/10.1158/2326-6066.CIR-14-0145
- (2015) Cancer Immunol Res. , vol.3 , Issue.2 , pp. 110-115
- Rodic, N.¹ Anders, R.A.² Eshleman, J.R.³ Lin, M.⁴ Xu, H.⁵ Kim, J.H.⁶ Beierl, K.⁷ Chen, S.⁸ Luber, B.S.⁹ Wang, H.¹⁰

8
- 84904024273
- Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy
- 24714771
- J.M.Taube, A.Klein, J.R.Brahmer, H.Xu, X.Pan, J.H.Kim, L.Chen, D.M.Pardoll, S.L.Topalian, R.A.Anders. Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy. Clin Cancer Res. 2014; 20(19):5064-74; PMID:24714771; http://dx.doi.org/10.1158/1078-0432.CCR-13-3271
- (2014) Clin Cancer Res. , vol.20 , Issue.19 , pp. 5064-5074
- Taube, J.M.¹ Klein, A.² Brahmer, J.R.³ Xu, H.⁴ Pan, X.⁵ Kim, J.H.⁶ Chen, L.⁷ Pardoll, D.M.⁸ Topalian, S.L.⁹ Anders, R.A.¹⁰

9
- 84920956732
- PD-1 blockade induces responses by inhibiting adaptive immune response
- 25428505
- P.C.Tumeh, C.L.Harview, J.H.Yearley, I.P.Shintaku, E.J.Taylor, L.Robert, B.Chmielowski, M.Spasic, G.Henry, V.Ciobanu, et al. PD-1 blockade induces responses by inhibiting adaptive immune response. Nature. 2014; 515(7528):568-71; PMID:25428505; http://dx.doi.org/10.1038/nature13954
- (2014) Nature , vol.515 , Issue.7528 , pp. 568-571
- Tumeh, P.C.¹ Harview, C.L.² Yearley, J.H.³ Shintaku, I.P.⁴ Taylor, E.J.⁵ Robert, L.⁶ Chmielowski, B.⁷ Spasic, M.⁸ Henry, G.⁹ Ciobanu, V.¹⁰

10
- 84863393623
- Selective BRAF inhibitors induce marked T-cell infiltration into human metastatic melanoma
- J.S.Wilmott, G.V.Long, J.R.Howle, L.E.Haydu, R.N.Sharma, J.F.Thompson, R.F.Kefford, P.Hersey, R.A.Scolyer. Selective BRAF inhibitors induce marked T-cell infiltration into human metastatic melanoma. Clin Cancer Res. 2012; 8(5):1386-94; http://dx.doi.org/10.1158/1078-0432.CCR-11-2479
- (2012) Clin Cancer Res. , vol.8 , Issue.5 , pp. 1386-1394
- Wilmott, J.S.¹ Long, G.V.² Howle, J.R.³ Haydu, L.E.⁴ Sharma, R.N.⁵ Thompson, J.F.⁶ Kefford, R.F.⁷ Hersey, P.⁸ Scolyer, R.A.⁹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.